Search
Returning search results with filters:
Remove filter for
Last updated: April 2022
Remove filter for
Last updated: 2022
Remove filter for
Type: Public advisory
Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 3 of 3 items.
Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
Pfizer Canada ULC is recalling all lots of the prescription drug Accupril (quinapril hydrochloride) in 10 mg, 20 mg and 40 mg strengths due to the…
AlertPublic advisory | 2022-04-21
Updated safety review of breast implants underscores the continuing importance of monitoring for cancer; increased risk with highly textured (macro-textured) implants
Health Canada has updated its 2019 and 2017 safety reviews on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare but serious cancer of the immune system that can develop next to a breast implant. This review found that there…
AlertPublic advisory | 2022-04-06
Health Canada warns Canadians that a Vertbaudet children’s bathrobe poses a flammability hazard
The product does not meet the flammability requirements for children’s sleepwear of the Children’s Sleepwear Regulations.
Loose-fitting children’s sleepwear can come in contact with flammable sources such as stove elements, candles, and matches more…
AlertPublic advisory | 2022-04-05